Fuling Technology
001356
KLT
831689
Hand Enterprise Solutions
300170
4
GRANDTECH
835184
5
Doushen(Beijing) Education & Technology Inc.
300010
CN Stock MarketDetailed Quotes
601958 Jinduicheng Molybdenum
- 10.45
- -0.03-0.29%
Market Closed Jan 23 15:00 CST
33.72BMarket Cap11.40P/E (TTM)
10.61High10.41Low138.24KlotVolume10.51Open10.48Pre Close145.37MTurnover0.43%Turnover Ratio10.87P/E (Static)3.23BShares13.0952wk High2.07P/B33.72BFloat Cap7.7052wk Low11.53Limit Up3.23BShs Float32.08Historical High9.43Limit Down1.91%Amplitude3.55Historical Low0.40Dividend TTM10.52Avg Price63.31KlotAsk3.83%Div YieldTTM100Lot Size71.98KlotBid
Jinduicheng Molybdenum Key Stats
All
YOY
| (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total operating revenue | 14.06%10.1B | 19.66%6.59B | 8.43%2.87B | 20.99%11.53B | 25.29%8.85B | 12.52%5.51B | 17.57%2.64B | 19.53%9.53B | 17.54%7.07B | 29.85%4.9B |
| Operating revenue | 14.06%10.1B | 19.66%6.59B | 8.43%2.87B | 20.99%11.53B | 25.29%8.85B | 12.52%5.51B | 17.57%2.64B | 19.53%9.53B | 17.54%7.07B | 29.85%4.9B |
| Other operating revenue | ---- | -0.56%45.51M | ---- | 6.48%112.65M | ---- | -18.58%45.77M | ---- | 51.09%105.8M | ---- | 13.35%56.21M |
| Total operating cost | 25.44%7.21B | 30.37%4.61B | 26.61%1.97B | 2.39%7.6B | 3.12%5.75B | -8.19%3.53B | -13.84%1.56B | 3.77%7.42B | 3.37%5.57B | 12.59%3.85B |
| Operating cost | 31.09%6.04B | 39.58%3.89B | 44.48%1.63B | -3.47%6B | -1.98%4.61B | -14.29%2.79B | -28.00%1.13B | -0.11%6.22B | -1.01%4.7B | 7.52%3.25B |
| Operating tax surcharges | -5.68%573.97M | -1.28%388.4M | -21.45%183.86M | 40.82%779.91M | 53.31%608.53M | 46.55%393.43M | 85.11%234.07M | 48.89%553.83M | 56.18%396.92M | 68.08%268.47M |
| Operating expense | -6.88%21.29M | -9.17%12.21M | 7.81%7.33M | 11.61%34.57M | 13.51%22.86M | 2.46%13.45M | 25.31%6.8M | 17.83%30.98M | 0.51%20.14M | -6.49%13.12M |
| Administration expense | 20.34%410.39M | 1.48%224.79M | 3.50%112.64M | 4.89%473.2M | -0.50%341.03M | 1.91%221.5M | 49.45%108.82M | 24.69%451.13M | 46.52%342.76M | 46.49%217.35M |
| Financial expense | -55.39%-32.28M | -32.14%-25.19M | -99.73%-11.46M | 23.73%-23.42M | 50.03%-20.77M | 24.36%-19.06M | -26.40%-5.74M | -29.57%-30.7M | -76.44%-41.58M | -33.63%-25.21M |
| -Interest expense (Financial expense) | -34.60%4.85M | -36.12%3.23M | -36.75%1.6M | -27.37%9.46M | 18.07%7.42M | 30.50%5.06M | 30.58%2.53M | 46.19%13.03M | 43.96%6.28M | 33.55%3.87M |
| -Interest Income (Financial expense) | -48.57%-47.32M | -29.94%-33.28M | -10.50%-16.15M | 0.87%-41.64M | 25.43%-31.85M | 6.00%-25.61M | -22.73%-14.62M | 21.55%-42M | -2.99%-42.72M | 14.26%-27.25M |
| Research and development | 3.73%193.61M | -16.18%112.84M | -39.43%53.12M | 66.98%335.59M | 21.92%186.65M | 11.67%134.62M | 99.51%87.71M | 4.04%200.98M | -2.52%153.1M | 36.23%120.55M |
| Credit Impairment Loss | 1.47%-35.09M | -43.93%-35.91M | -9.00%-29.63M | 120.69%30.1M | 52.80%-35.61M | 64.38%-24.95M | 10.73%-27.18M | -1,292.89%-145.45M | -155.66%-75.45M | -297.39%-70.04M |
| Asset Impairment Loss | 67.64%-5.12M | 68.52%-5.72M | 74.91%-3.6M | 84.53%-18.02M | 48.29%-15.83M | -74.33%-18.17M | -890.36%-14.34M | -13.61%-116.47M | -5,116.39%-30.6M | -895.82%-10.43M |
| Other net revenue | 46.46%15.62M | 85.78%-2.07M | 59.96%-12.53M | 184.32%196.49M | 110.78%10.66M | 81.85%-14.54M | 6.98%-31.28M | -126.43%-233.03M | -441.49%-98.92M | -476.03%-80.14M |
| Invest income | 14.41%38.73M | 47.28%26.13M | 184.10%16.03M | 3,371.14%67.67M | 316.20%33.85M | 241.89%17.74M | 188.46%5.64M | 91.65%-2.07M | 14.20%-15.66M | -13.87%-12.5M |
| -Including: Investment income associates | ---- | ---- | ---- | 765.73%21.88M | ---- | ---- | ---- | -18.77%-3.29M | ---- | ---- |
| Asset deal income | ---- | --6K | --6K | -98.78%53.1K | ---- | ---- | ---- | 2,716.06%4.36M | 5,887.44%4.43M | --32.08K |
| Other revenue | -39.48%17.1M | 23.86%13.42M | 1.50%4.67M | 338.72%116.69M | 53.91%28.25M | -15.27%10.84M | -1.01%4.6M | -23.99%26.6M | -36.61%18.36M | -4.42%12.79M |
| Operating profit | -6.84%2.9B | 1.16%1.99B | -16.35%883.43M | 120.10%4.13B | 123.73%3.12B | 102.56%1.96B | 158.43%1.06B | 161.32%1.88B | 131.82%1.39B | 185.14%968.98M |
| Add:Non operating Income | 1,529.25%9.82M | 1,616.32%9.14M | 1,092.47%29.81K | 238.34%1.31M | 282.89%602.57K | 415.93%532.7K | -81.88%2.5K | -91.59%388.24K | -95.96%157.37K | -97.44%103.25K |
| Less:Non operating expense | -66.35%1.85M | -70.47%1.63M | ---- | 3.83%6.69M | -8.05%5.51M | -8.05%5.51M | --37.78K | 132.55%6.44M | 138.89%5.99M | 895.48%5.99M |
| Total profit | -6.43%2.91B | 1.80%1.99B | -16.35%883.46M | 120.52%4.12B | 124.32%3.11B | 103.28%1.96B | 158.41%1.06B | 159.81%1.87B | 130.32%1.39B | 180.58%963.1M |
| Less:Income tax cost | -4.08%447.86M | 5.17%303.71M | 84.40%160.36M | 117.23%614.03M | 107.44%466.89M | 92.02%288.78M | 49.61%86.96M | 153.67%282.66M | 111.22%225.07M | 130.43%150.39M |
| Net profit | -6.85%2.46B | 1.21%1.69B | -25.39%723.1M | 121.11%3.51B | 127.59%2.64B | 105.36%1.67B | 176.45%969.12M | 160.93%1.59B | 134.42%1.16B | 192.35%812.71M |
| Net profit from continuing operation | -6.85%2.46B | 1.21%1.69B | -25.39%723.1M | 121.11%3.51B | 127.59%2.64B | 105.36%1.67B | 176.45%969.12M | 160.93%1.59B | 134.42%1.16B | 192.35%812.71M |
| Less:Minority Profit | -12.77%267.32M | 3.47%182.37M | -34.13%89.9M | 62.33%408.68M | 62.84%306.46M | 19.30%176.25M | 80.36%136.47M | 122.35%251.76M | 152.84%188.19M | 304.11%147.74M |
| Net profit of parent company owners | -6.07%2.19B | 0.95%1.51B | -23.95%633.2M | 132.19%3.1B | 140.11%2.34B | 124.49%1.49B | 202.90%832.65M | 169.76%1.33B | 131.17%973.23M | 175.43%664.97M |
| Earning per share | ||||||||||
| Basic earning per share | -6.08%0.68 | 0.86%0.467 | -24.03%0.196 | 134.15%0.96 | 139.74%0.724 | 124.76%0.463 | 203.53%0.258 | 173.33%0.41 | 132.31%0.302 | 174.67%0.206 |
| Diluted earning per share | -6.08%0.68 | 0.86%0.467 | -24.03%0.196 | 134.15%0.96 | 139.74%0.724 | 124.76%0.463 | 203.53%0.258 | 173.33%0.41 | 132.31%0.302 | 174.67%0.206 |
| Other composite income | -123.75%-376.39K | -76.54%455K | 104.49%45.33K | -89.68%812.43K | -80.58%1.58M | 1.94%1.94M | -324.22%-1.01M | 875.87%7.87M | 2,715.34%8.16M | 655.53%1.9M |
| Other composite income of parent company owners | -123.75%-301.11K | -76.54%364K | 104.49%36.26K | -89.68%649.95K | -80.58%1.27M | 1.94%1.55M | -324.22%-807.55K | 875.87%6.3M | 2,715.34%6.53M | 655.53%1.52M |
| Other composite income of minority owners | -123.75%-75.28K | -76.54%91K | 104.49%9.07K | -89.68%162.49K | -80.58%316.94K | 1.94%387.87K | -324.22%-201.89K | 875.87%1.57M | 2,715.34%1.63M | 655.53%380.48K |
| Total composite income | -6.92%2.46B | 1.12%1.69B | -25.30%723.15M | 120.07%3.51B | 126.14%2.64B | 105.12%1.67B | 176.35%968.11M | 162.66%1.59B | 135.93%1.17B | 193.40%814.61M |
| Total composite income of parent company owners | -6.14%2.19B | 0.87%1.51B | -23.88%633.24M | 131.15%3.1B | 138.64%2.34B | 124.21%1.49B | 202.82%831.85M | 171.48%1.34B | 132.59%979.75M | 176.37%666.49M |
| Total composite income of minority owners | -12.89%267.24M | 3.30%182.46M | -34.02%89.91M | 61.39%408.85M | 61.61%306.78M | 19.25%176.63M | 80.21%136.27M | 124.14%253.33M | 154.84%189.83M | 305.91%148.12M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- |
| Auditor | -- | -- | -- | Daxin Certified Public Accountants (Special General Partnership) | -- | -- | -- | Daxin Certified Public Accountants (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.